MAPT and Alzheimer disease: The results of this study suggest that P-Tau Thr181 and Thr217, found in CSF during early disease stages, are not necessarily the most pathogenic tau species, also underscoring the importance of soluble tau oligomeric assemblies over tau fibrils in AD.